vamstarReport/A in Pharma. Medlech& Biotech:Unlocking CommerciaSuccess一
Contents01/ExecutiveSummary202/ Introduction5co03/Al-DrivenPricingOntimisation04/Enhancing Market Access with Alne05/NavigatingLossofExclusivity(LOE)二06/IntegratingValue-BasedProcurement/VRP)andESa07/Tools and TechnologiesPoweringAl inLifeSciences1408/vamstar
01/Executive SummaryArtificial intelligence (Al) has emerged as a transformative force in the life sciences industryrevolutionisingcommercialand orocurementoperations in pharmaceuticals.medtech. and biotechBy leveraging Al-driven analytics, real-world evidence (RWE),and predictive,modellinaorganisationscanenhanceefficiencvaccelerateinnovationanddevelopdata-driven strategies to address complex market challenges. Thesechallenges include navigating fragmented regulatory landscapes, optimisingoricing strategies. ensuring cost-efficient operations, and adapting toevolvingvalue-basedcaremodels.The lifesciences industrv operates in a dynamic regulatorv environmentrequiring companies to align innovation, affordability, and accessiblitv withIifecrycle management.Al-powered platforms like Polarisfrom Vamstar enableorganisations to break down data silos, convert fragmented information intoactionable insights, and develop predictive strategies for sustained growth.However, Al adoption must be tallored to an organisation's unique challengesmaking expertengagerent and customised solutionsessential for maximisingAl's potential and securing competitive advantagevamstar
01/ExecutiveSummary/continuedKey TakeawaysIMPROVINGOPERATINGMARGINSThe life sciences industry faces growing pressure to enhance operationalefficiency. With SG&A costs surpassing 40%, agentic automation-encompassing solutions such as salesenablement and CRM automation-unlockssubstantialvaluefororganisationsAIASASTRATEGICENABLEPAdvanced analytics, Real-World Evidence (RWE), and predictive modelling arereshaping how life sciences organisations address pricing, market access, andsustainability targets.DRIVINGREVENUEGROWTH:Al-driven pricing optimisation helps companies reclaim up to 22% oflosvalue caused by outdated or static methodologiesvamstar
01/ExecutiveSummary/continuedSTREAMLININGMARKETACCESSAl-powered tools, such as Polaris, simplify navigation of fragmented regulatorylandscapes,ensuring complianceand fostering patient-centricstrategiesAl-driven insights enhance transparency in value-based procurement (VBP and environmental, social, and governance (ESG) decision-making.TAILOREDAISOLUTIONS:Engaging with Al specialists ensures bespoke strategies that align with anorganisation'suniqueneeds andcommercialobjectivesContactus->DiscoverhowAl canpropelyour commercialoutcomes,contactustodayforatailoredconsultation,vamstar
02/Introduction The ife sciences industry stands at the intersection of evolving global regulations;patient-centric care models. and cost-efficiency pressures. Regulations oftenvary significantly by region, requiring adaptive and agile commercial strategiesOrganisations must balance operational efficiencies, pricingoptimisation, mark...
